MIL •
Healthcare •
Biotechnology •
Quote as of 09/11/2026 17:35
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeMIL
Market Capitalization49,785 mln
Float327 mln
Earnings Date11/06/2026
Piotroski F-Score
1
/ 9
Very weak
Beneish M-Score
-3.83
Highly reliable
Relative Strength
92
/ 100
Top performer
Debt / Equity
0.19
Very low leverage
Pre-Tax Margin
-140%
Severely loss-making
ROE
-37.92
Deeply negative
Business Description
Founded in 2010 and based in Cambridge, Massachusetts, Moderna is a biotechnology company that develops medicines using messenger RNA technology. Its product portfolio spans vaccines for respiratory illnesses, viral infections, and bacterial diseases, as well as treatments for certain cancers and rare genetic conditions. The company works alongside prominent partners including Merck, Vertex Pharmaceuticals, the Bill & Melinda Gates Foundation, and OpenAI to advance its research and bring new treatments to patients across the United States and around the world.
